Hims & Hers Health Inc - Class A
NYSE: HIMS
$28.09
-$0.05 (-0.2%)
Closing Price on April 25, 2025
HIMS Stock Chart and Intraday Price
HIMS Stock Data
| Asset Type | Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Address | 333 S. GRAND AVE., 28TH FLOOR, LOS ANGELES, CA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 2,810.96M USD |
| Shares Outstanding | 205,873,000 |
HIMS Articles
Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to...
Published:
Live Updates Live Coverage Has Ended S&P's Losing Streak, Mag 7 Correction 3:29 pm by Gerelyn Terzo The markets remain under pressure as of mid-afternoon, with the exception of the Dow Jones...
Published:
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was over. It said the Danish pharmaceutical had sufficient supply of its...
Published:
Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. About This Article Just this morning, the US FDA said Novo Nordisk’s popular...
Published:
Live Updates Live Coverage Has Ended Quantum Leap 3:39 pm by Gerelyn Terzo Stocks have managed to find their way into positive territory as of late afternoon. The Fed is looking for further inflation...
Published:
Stock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating inflation to rise in 2025, potentially depressing consumer spending and dissuading...
Published:
Last Updated:
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly (NYSE:LLY) has become the industry leader in a class of drugs called...
Published:
Live Updates Live Coverage Has Ended Nasdaq Composite Off Its Daily Highs 2:10 pm by Eric Bleeker The Nasdaq Composite has fallen from its highs today but is still up about 1% as of 2:10 p.m. ET....
Published:
Capitalizing on the popularity of weight-loss drugs like Wegovy and Zepbound, Hims & Hers Health (NYSE:HIMS) has exploited a loophole in Food & Drug Administration regulations to bring to...
Published:
Summer has officially begun, but some stocks are receiving a chilly reception today. Among them, Hims & Hers Health (NYSE: HIMS), a telehealth and wellness platform, is down over 11% on the day...
Published:
